The Nanotechnology Characterization Laboratory (NCL), part of the National Cancer Institute’s Alliance for Nanotechnology in Cancer, was established in 2004 to serve as a national resource to investigators developing nanotechnology oncology therapeutics or diagnostics. The NCL has since established a thorough cascade of analyses to characterize a nanoparticle’s physical and chemical properties, in vitro cytotoxicity, … Continue reading NCL/ SAIC Frederick Inc.